478 related articles for article (PubMed ID: 12815174)
1. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
[TBL] [Abstract][Full Text] [Related]
2. Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.
Tränkle C; Mies-Klomfass E; Cid MH; Holzgrabe U; Mohr K
Mol Pharmacol; 1998 Jul; 54(1):139-45. PubMed ID: 9658199
[TBL] [Abstract][Full Text] [Related]
3. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
[TBL] [Abstract][Full Text] [Related]
4. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
[TBL] [Abstract][Full Text] [Related]
5. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
Schröter A; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
[TBL] [Abstract][Full Text] [Related]
6. Allosteric binding sites on muscarinic acetylcholine receptors.
Wess J
Mol Pharmacol; 2005 Dec; 68(6):1506-9. PubMed ID: 16183853
[TBL] [Abstract][Full Text] [Related]
7. Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors.
Tränkle C; Weyand O; Schröter A; Mohr K
Mol Pharmacol; 1999 Nov; 56(5):962-5. PubMed ID: 10531401
[TBL] [Abstract][Full Text] [Related]
8. M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.
Tränkle C; Andresen I; Lambrecht G; Mohr K
Mol Pharmacol; 1998 Feb; 53(2):304-12. PubMed ID: 9463489
[TBL] [Abstract][Full Text] [Related]
9. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
Hu J; Wang SZ; Forray C; el-Fakahany EE
Mol Pharmacol; 1992 Aug; 42(2):311-21. PubMed ID: 1513329
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Mg2+ with the allosteric site of muscarinic M2 receptors.
Burgmer U; Schulz U; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):363-70. PubMed ID: 9606020
[TBL] [Abstract][Full Text] [Related]
11. Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors.
Avlani V; May LT; Sexton PM; Christopoulos A
J Pharmacol Exp Ther; 2004 Mar; 308(3):1062-72. PubMed ID: 14711931
[TBL] [Abstract][Full Text] [Related]
12. Atypical muscarinic allosteric modulation: cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptors.
Tränkle C; Dittmann A; Schulz U; Weyand O; Buller S; Jöhren K; Heller E; Birdsall NJ; Holzgrabe U; Ellis J; Höltje HD; Mohr K
Mol Pharmacol; 2005 Dec; 68(6):1597-610. PubMed ID: 16157694
[TBL] [Abstract][Full Text] [Related]
13. Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication.
Jepsen K; Lüllmann H; Mohr K; Pfeffer J
Pharmacol Toxicol; 1988 Sep; 63(3):163-8. PubMed ID: 3054859
[TBL] [Abstract][Full Text] [Related]
14. Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors.
Franken C; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):107-12. PubMed ID: 10685864
[TBL] [Abstract][Full Text] [Related]
15. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
Christopoulos A; Mitchelson F
Mol Pharmacol; 1994 Jul; 46(1):105-14. PubMed ID: 8058045
[TBL] [Abstract][Full Text] [Related]
17. Identification of various allosteric interaction sites on M1 muscarinic receptor using 125I-Met35-oxidized muscarinic toxin 7.
Fruchart-Gaillard C; Mourier G; Marquer C; Ménez A; Servent D
Mol Pharmacol; 2006 May; 69(5):1641-51. PubMed ID: 16439611
[TBL] [Abstract][Full Text] [Related]
18. Binding of orthosteric ligands to the allosteric site of the M(2) muscarinic cholinergic receptor.
Redka DS; Pisterzi LF; Wells JW
Mol Pharmacol; 2008 Sep; 74(3):834-43. PubMed ID: 18552124
[TBL] [Abstract][Full Text] [Related]
19. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
Krejcí A; Tucek S
Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the hexamethonium derivative W84, an allosteric effector at muscarinic cholinoreceptors, with rat brain nicotinic binding sites.
Leithäuser F; Mohr K; Staschen CM
Pharmacol Toxicol; 1990 Oct; 67(4):317-21. PubMed ID: 2077524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]